What is the appropriate treatment for a pregnant woman with ascariasis?

Treatment of Ascariasis in Pregnancy

Pregnant women with ascariasis should be treated with pyrantel pamoate as the drug of choice, or alternatively with albendazole or mebendazole after the first trimester if pyrantel pamoate is unavailable. 1, 2

First-Line Treatment Recommendation

• Pyrantel pamoate is the preferred anthelmintic for pregnant women with ascariasis across all trimesters of pregnancy 1, 2
• This recommendation prioritizes fetal safety while effectively treating the maternal infection 1

Alternative Treatment Options

After First Trimester

• Albendazole 400 mg as a single oral dose can be used after the first trimester if pyrantel pamoate is unavailable 3, 4
• Mebendazole 500 mg as a single oral dose is another alternative after the first trimester 3, 1
• Albendazole demonstrates cure rates up to 90% for Ascaris in pregnant women, compared to ≤70% for mebendazole 4
• Meta-analysis data confirms albendazole is safe for the mother with no increased risk of pregnancy loss, preterm delivery, or adverse effects on hemoglobin concentration compared to placebo 4

First Trimester Considerations

• Treatment should ideally be deferred until after the first trimester when using albendazole or mebendazole, though pyrantel pamoate can be used throughout pregnancy 1, 5
• The embryo- and fetotoxic effects of anthelmintics must be carefully considered, with medical practices adapted to the trimester of pregnancy 5

Clinical Context and Rationale for Treatment

• All pregnant women with ascariasis warrant treatment, even if asymptomatic, to prevent complications from worm migration 1, 2
• Complications in pregnancy include biliary obstruction, intestinal obstruction, cholangitis, pancreatitis, and malnutrition—all of which pose significant maternal and fetal risks 6, 1, 7
• Pregnant women in endemic areas are particularly prone to developing biliary ascariasis, which can present with jaundice, abdominal pain, and biliary colic 7

Management of Complicated Ascariasis in Pregnancy

Biliary Ascariasis

• Conservative management with anthelmintic therapy is successful in 60% of pregnant patients with biliary ascariasis 7
• Ultrasonography is the diagnostic tool of choice, avoiding radiation exposure to the fetus 7
• Endoscopic extraction may be required in 30-40% of cases that fail conservative management, with lead shielding of the fetus and limited fluoroscopic exposure to minimize teratogenic risk 7
• Surgical intervention is reserved for failures of conservative and endoscopic management, though it carries risks of fetal wastage and premature labor 7

Intestinal Obstruction

• Partial obstructions can be managed conservatively with nasogastric decompression, intravenous fluids, and anthelmintics, often resulting in spontaneous worm passage 8
• Complete obstructions may require surgical intervention 1

Important Clinical Pitfalls

• Do not withhold treatment in asymptomatic pregnant women—the risk of complications from untreated ascariasis outweighs any theoretical medication risks, particularly when using pyrantel pamoate 1, 2
• Avoid using ivermectin in pregnancy—it has lower cure rates (29% for hookworm) and insufficient safety data in pregnant populations 4
• Routine deworming of women of childbearing age is recommended in endemic areas to prevent ascariasis during pregnancy 7
• Be aware that most treated patients in endemic areas become reinfected within months, necessitating health education about sanitation and hygiene 1

Monitoring and Follow-up

• Average cure rates with appropriate anthelmintic treatment exceed 95% 1
• No serious adverse events have been attributable to albendazole or mebendazole when used in pregnancy after the first trimester 4
• Gestational age and accurate recognition of specific pathology are critical for safe and effective management 7